These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4994065)

  • 1. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension.
    Banerjee S; Bandyopadhyay A; Bhattacharjee RC; Mukherjee AK; Halder AK
    J Pharm Sci; 1971 Jan; 60(1):153-5. PubMed ID: 4994065
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED
    Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of new active forms of chlormphenicol palmitate in the treatment of typhoid and paratyphoid fevers in children.
    Hegazy MR; Abdel-Wahab MF; Kaddah N; Hathoot S; Wishahy A
    J Egypt Med Assoc; 1971; 54(1):35-46. PubMed ID: 5002925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems in the rectal use of chloramphenicol].
    Briedigkeit W; Göres E; Schneeweiss B; Wachholz E; Wiegand U
    Padiatr Grenzgeb; 1972; 11(4):241-51. PubMed ID: 4662526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of tween 8OR concentration on the particle dimension, rheologic properties and physical stability of chloramphenicol palmitate suspensions].
    Moës A
    J Pharm Belg; 1970; 25(5):409-22. PubMed ID: 5494311
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma chloramphenicol levels in dogs after the administration of four different oral preparations of chloramphenicol.
    Watson AD
    Aust Vet J; 1973 Oct; 49(10):460-2. PubMed ID: 4774387
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of chloramphenicol (Leukomycin) in cats. Serum concentrations after oral, subcutaneous and intramuscular administration].
    Förster D; Scheer M; Schulz HP
    Berl Munch Tierarztl Wochenschr; 1976 Jul; 89(13):258-62. PubMed ID: 985312
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.
    Aguiar AJ; Krc J; Kinkel AW; Samyn JC
    J Pharm Sci; 1967 Jul; 56(7):847-53. PubMed ID: 6034828
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood concentration of chloramphenicol in horses after intramuscular or oral administration.
    Oishi S
    Nihon Juigaku Zasshi; 1968 Feb; 30(1):25-8. PubMed ID: 5692325
    [No Abstract]   [Full Text] [Related]  

  • 12. The monitoring of serum chloramphenicol levels in children with severe infections.
    Ekblad H; Ruuskanen O; Lindberg R; Iisalo E
    J Antimicrob Chemother; 1985 Apr; 15(4):489-94. PubMed ID: 4008381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of chloramphenicol sodium succinate after intramuscular administration in children.
    Shann F; Linnemann V; Mackenzie A; Barker J; Gratten M; Crinis N
    N Engl J Med; 1985 Aug; 313(7):410-4. PubMed ID: 4022068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of manufacturing conditions and physical properties of sulfonamide and palmitate suspensions of chloramphenicol on their stability and resorption].
    Moës A
    Mem Acad R Med Belg; 1969; 5(6):797-899. PubMed ID: 5360537
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problem of rectal chloramphenicol administration].
    Schweier P
    Anasthesiol Intensivmed Prax; 1974; 9(1):13-4. PubMed ID: 4464788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation, hydrolysis and resorption of chloramphenicol palmitate-suspensions].
    Braeckman P; van Severen R; Dony J; de Roeck A
    Pharmazie; 1966 Dec; 21(12):757-60. PubMed ID: 6001165
    [No Abstract]   [Full Text] [Related]  

  • 18. Rate studies on dissolution and enzymatic hydrolysis of chloramphenicol palmitate.
    Andersgaard H; Finholt P; Gjermundsen R; Hoyland T
    Acta Pharm Suec; 1974 Jun; 11(3):239-48. PubMed ID: 4839734
    [No Abstract]   [Full Text] [Related]  

  • 19. Chloramphenicol disposition in infants and children.
    Friedman CA; Lovejoy FC; Smith AL
    J Pediatr; 1979 Dec; 95(6):1071-7. PubMed ID: 387936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some metabolic effects of chloramphenicol in rhesus monkeys.
    Bandyopadhyay A; Banerjee S
    Indian J Biochem; 1971 Sep; 8(3):176-8. PubMed ID: 4257877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.